CABB Tech Stack
Contract manufacturing for complex molecules in pharma, ag, and materials
CABB is a European contract development and manufacturing organization (CDMO) with ~1,100 employees across six production sites, generating roughly €500M in annual revenue. The company is actively hiring across manufacturing and engineering roles—particularly in quality and automation—while pursuing oligonucleotide production and life sciences expansion. The project mix (control cabinet design, analytical method development, MSR infrastructure) and pain-point focus on regulatory compliance and cost control suggest a manufacturing operation scaling toward higher-margin biotech molecules while managing operational complexity.
Tech Stack 11 technologies
What CABB Is Building
◆Challenges
- Cost and deadline control
- Meeting regulatory requirements
- Building compliance management system
- Risk assessment and mitigation
- Security incidents
- System security improvement
- Acquiring new customers
- Expanding presence in life sciences
- Strategic account development
▲Active Projects
- New and renovation projects
- Control cabinet design
- Msr infrastructure improvement
- Internal audit execution
- External risk audit coordination
- New analytical method development
- Customer method implementation
- Global life sciences strategy implementation
- Oligonucleotide value chain focus
Hiring Activity
Department
Seniority
Notable leadership hires: Quality Control Lead
